Document is current
Any future updates will be listed below
-
Authors
Hayashi, Yu
Okumura, Hiroki
Arioka, Yuko https://orcid.org/0000-0002-1792-8812
Kushima, Itaru https://orcid.org/0000-0002-0018-5178
Mori, Daisuke https://orcid.org/0000-0002-9072-2546
Lo, Tzuyao
Otgonbayar, Gantsooj
Kato, Hidekazu https://orcid.org/0000-0001-9995-504X
Nawa, Yoshihiro https://orcid.org/0000-0003-3164-2519
Kimura, Hiroki
Aleksic, Branko https://orcid.org/0000-0001-8982-4580
Ozaki, Norio https://orcid.org/0000-0002-7360-4898
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP21wm0425007, JP19dm0207075, JP19ak0101113, JP21dk0307103, JP22ek0109601, JP22tm0424222)
- License Information
-
More Information
Article History
Received: 14 February 2023
Revised: 19 May 2024
Accepted: 23 May 2024
First Online: 3 June 2024
Competing interests
: Dr. N. Ozaki has received research support or speakers’ honoraria from or has served as a joint researcher with, or a consultant to, Sumitomo Pharma, Otsuka, Viatris, Eisai, Mochida, Kyowa Pharmaceutical Industry, Nihon Medi-Physics, Nippon Chemiphar, Medical Review, Nippon Boehringer Ingelheim, SUSMED, outside the submitted work.
: This study was performed in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Nagoya University (approval number: 2012-0184). All subjects provided written informed consent.
